Top Wall Street analysts like these 3 dividend stocks for solid returns

The article highlights three dividend-paying stocks—Kinetik yielding about 7.0%, SLB at 2.5%, and IBM at 2.7%—that analysts see as attractive amid a potentially higher-rate backdrop. Kinetik's price target was raised to $53 from $50, SLB was reiterated Buy with a $63 target, and IBM was upgraded to a $315 target from $300 on AI- and infrastructure-driven growth. Overall tone is constructive on capital returns and long-term fundamentals, but the piece is mainly analyst commentary rather than a market-moving catalyst.

Analysis

The common thread is not “yield” but balance-sheet optionality: each name is monetizing a different scarcity premium. KNTK is the cleanest expression of physical bottleneck value — a takeaway/processing asset in a constrained basin should keep pricing power elevated until new capacity lands, and the real upside is not the current distribution but the potential re-rating from being a strategic asset with takeout value. The market is likely underweighting how much of KNTK’s cash flow durability is driven by permitting friction and sour-gas complexity, which is a moat measured in years, not quarters.

SLB sits in a different regime: its dividend is modest, but the equity can compound if international activity remains insulated from North American softness. The second-order effect is that capital discipline across E&Ps forces more spending into high-return international/deepwater projects, which benefits the best global service franchises before it benefits the commodity cycle. A key risk is that the thesis is more back-half weighted; if exploration FIDs slip, SLB can look expensive on near-term earnings even as the medium-term setup improves.

IBM is the most interesting contrarian because the market usually treats it as a slow-growth value/defensive income name, but the AI lever is actually operating leverage in infrastructure, not just software hype. If AI workloads keep pushing beyond training into inference and transaction-level compute, IBM’s installed base gets more valuable without needing share gains everywhere. The surprise is that this can support both a higher multiple and a sturdier dividend, but only if capex translation into revenue remains visible; otherwise the stock can stall despite good narrative momentum.

Overall, the setup is moderately bullish but uneven: KNTK offers the highest idiosyncratic upside with event-driven catalysts, SLB is a cyclical quality long with a slower burn, and IBM is a multiple-expansion story disguised as a dividend name. The consensus may be underestimating how much rate anxiety is pushing investors toward yield, which can keep these names bid even if the macro backdrop softens.

Key Decisions for Investors

• Long KNTK on pullbacks over the next 1-3 months; target a re-rating toward strategic value/takeout optionality, with downside capped by yield support and distribution growth. Best risk/reward of the trio if takeaway constraints persist.
• Buy SLB on any sector-wide weakness and hold 6-12 months; the thesis is global activity normalization, not immediate quarter-to-quarter beats. Use it as a higher-quality way to own international oilfield capex than more levered E&Ps.
• Add IBM as a defensive growth compounder for 6-18 months, especially if AI infrastructure spend broadens beyond GPUs. The dividend reduces timing risk while the multiple can expand if Z/Storage AI monetization keeps accelerating.
• Pair trade: long KNTK / short a lower-yield midstream peer with weaker basin positioning for 3-6 months. The edge is moat plus growth visibility versus simple yield compression.
• If using options, prefer SLB call spreads rather than outright calls into the next earnings cycle; the market may lag the medium-term story but near-term execution risk remains. This keeps theta manageable while preserving upside if global activity surprises higher.